Cozart names Elitech as French distributor

20 March 2006

UK-based medical diagnostics company Cozart says that it has appointed Elitech Group to act as its distributor for France through its subsidiary Elitech France SAS.

Elitech will sell Cozart's broad portfolio of drugs-of-abuse testing products, including the Cozart RapiScan oral fluid on-site drug testing system, the Cozart microplate Elisa drug testing kits, and point-of-care urine drug kits to the police, laboratories and other markets. Cozart will continue to sell directly to the French customs authorities.

The UK firm says that Elitech Group is the largest independent in vitro diagnostic supplier in France, employing 138 people, and has turnover of around 28.0 million euros ($33.4 million) for the past 12 months. Elitech France employs 58 people based in France including 30 field-based sales personnel and will give geographical reach for sales and sales support across the whole of France. This will be supported by Cozart's technical and sales personnel including Cozart's international operations director, Paul Kennedy, who is based in Paris.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight